Fc binding fragments comprising a CD137 antigen-binding site
US12103976B2 · kind B2 · utility
3Cited by
19References
22Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 12, 2019 |
| Grant date | Oct 1, 2024 |
| Priority date | — |
| Expiry date | Feb 1, 2042 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2318/10
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to specific binding members that bind CD137. The specific binding members comprise a CD137 antigen-binding site located in a constant domain of the specific binding member and find application in the treatment of cancer and infectious diseases, for example.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.